Literature DB >> 10090137

Twenty-four hour profile of blood pressure in patients with acromegaly. Correlation with demographic, clinical and hormonal features.

M Terzolo1, C Matrella, A Boccuzzi, S Luceri, M Borriero, G Reimondo, A Pia, E Rovero, P Paccotti, A Angeli.   

Abstract

Cardiovascular events are frequently reported in patients with acromegaly and they are usually related to arterial hypertension. Aim of the present study was to assess the 24-hour profile of blood pressure (BP) and heart rate (HR) in patients with active acromegaly and to correlate them with clinical and hormonal data. Sixteen patients and 16 healthy, age and sex matched subjects underwent ambulatory blood pressure monitoring by means of a portable automatic device (SpaceLabs monitor 90207, Kontron) with measurements every 20 minutes for 24 hours. The presence of the nocturnal fall was assessed by the calculation of the night-day systolic and diastolic ratio. The mean 24-hour diastolic BP was significantly higher in acromegalic patients than in controls (79.1+/-11.5 mmHg vs 70.8+/-5.3 mmHg, p<0.05) and the circadian diastolic profile was flatten. In fact, 10/16 patients were defined as nondippers while this figure was 2/16 in the control group (62% vs 12%, p<0.01). Also the mean 24-hour systolic BP was higher in acromegalic patients than in controls (124.8+/-17.2 mmHg vs 114.1+/-8.6 mmHg, p<0.05). The circadian systolic profile paralleled that of diastolic and was flatten, without a significant nocturnal fall. Ten out of 16 patients were nondippers compared to 2/16 controls (62 vs 12%, p<0.01). No significant correlation was found between mean 24-hour BP, either diastolic or systolic, and demographic or hormonal characteristics of the patients. HR patterns did not differ between patients and controls and were characterized by a prominent nocturnal fall.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090137     DOI: 10.1007/BF03345478

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  35 in total

1.  Acromegaly.

Authors:  G J HAMWI; T G SKILLMAN; K C TUFTS
Journal:  Am J Med       Date:  1960-10       Impact factor: 4.965

2.  Does ambulatory blood pressure monitoring improve the diagnosis of secondary hypertension?

Authors:  Y Imai; K Abe; M Munakata; H Sakuma; J Hashimoto; K Imai; H Sekino; K Yoshinaga
Journal:  J Hypertens Suppl       Date:  1990-12

3.  Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984.

Authors:  B A Bengtsson; S Edén; I Ernest; A Odén; B Sjögren
Journal:  Acta Med Scand       Date:  1988

4.  Doppler echocardiographic patterns in patients with acromegaly.

Authors:  M Terzolo; L Avonto; C Matrella; R Pozzi; S Luceri; G Borretta; F Pecchio; G Ugliengo; G P Magro; G Reimondo
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

5.  24-hour profiles of blood pressure and heart rate in Cushing's syndrome: relationship between cortisol and cardiovascular rhythmicities.

Authors:  A Piovesan; M Panarelli; M Terzolo; G Osella; C Matrella; P Paccotti; A Angeli
Journal:  Chronobiol Int       Date:  1990       Impact factor: 2.877

6.  Plasma renin activity and aldosterone secretion in patients with acromegaly.

Authors:  J P Cain; G H Williams; R G Dluhy
Journal:  J Clin Endocrinol Metab       Date:  1972-01       Impact factor: 5.958

7.  Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly.

Authors:  G Deray; M Rieu; M A Devynck; M G Pernollet; P Chanson; J P Luton; P Meyer
Journal:  N Engl J Med       Date:  1987-03-05       Impact factor: 91.245

8.  Evidence of subclinical heart muscle dysfunction in acromegaly.

Authors:  E A Jonas; J F Aloia; F J Lane
Journal:  Chest       Date:  1975-02       Impact factor: 9.410

9.  Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension.

Authors:  K Shimada; A Kawamoto; K Matsubayashi; M Nishinaga; S Kimura; T Ozawa
Journal:  J Hypertens       Date:  1992-08       Impact factor: 4.844

10.  Ascertainment and natural history of treated acromegaly in Northern Ireland.

Authors:  C M Ritchie; A B Atkinson; A L Kennedy; A R Lyons; D S Gordon; T Fannin; D R Hadden
Journal:  Ulster Med J       Date:  1990-04
View more
  5 in total

Review 1.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

Review 2.  Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.

Authors:  Ana M Ramos-Leví; Mónica Marazuela
Journal:  Endocrine       Date:  2017-01-02       Impact factor: 3.633

3.  Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study.

Authors:  A Giustina; T Mancini; P F Boscani; E de Menis; E degli Uberti; E Ghigo; E Martino; F Minuto; A Colao
Journal:  J Endocrinol Invest       Date:  2008-08       Impact factor: 4.256

Review 4.  Acromegalic cardiomyopathy: a review of the literature.

Authors:  M P Matta; P Caron
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

Review 5.  Pathogenesis and prevalence of hypertension in acromegaly.

Authors:  M Bondanelli; M R Ambrosio; E C degli Uberti
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.